*ST美谷(000615) - 2024 Q2 - 季度业绩预告

Financial Performance - The company expects a net loss attributable to shareholders of between 42 million and 58 million yuan for the first half of 2024, compared to a loss of 41.19 million yuan in the same period last year [2]. - The net loss after deducting non-recurring gains and losses is also projected to be between 42 million and 58 million yuan, compared to a loss of 45.59 million yuan in the previous year [2]. - Basic earnings per share are expected to be a loss of between 0.0550 yuan and 0.0760 yuan, compared to a loss of 0.0540 yuan per share in the same period last year [2]. Market Conditions - The decline in profit is attributed to insufficient overall market demand for viscose filament products and a decrease in average selling prices, which further squeezed profit margins [4]. - The medical beauty business faced intensified competition and increased difficulty in customer acquisition, leading to a year-on-year decrease in revenue and profit [4]. Forecast and Reporting - The performance forecast is based on preliminary calculations by the company's finance department and has not been audited by an external auditor [5]. - The reporting period for the performance forecast is from January 1, 2024, to June 30, 2024 [5].